Palliation of soft tissue cancer pain with radiofrequency ablation.
The purpose of this study was to analyze the feasibility, safety, and efficacy of radiofrequency ablation (RFA) to treat pain from soft tissue neoplasms. RFA was performed on 15 painful soft tissue tumors in 14 patients. Tumors varied in histology and location and ranged in size from 2 to 20 cm. Patient pain was assessed using the Brief Pain Inventory (BPI) at baseline and 1 day, 1 week, 1 month, and 3 months post RFA. All patients had unresectable tumors or were poor operative candidates whose pain was poorly controlled by conventional treatment methods. BPI scores were divided into two categories: pain severity and interference of pain. Although not all scores were statistically significant, all mean scores trended down with increased time post ablation. Based on these outcomes, RFA appears to be a low-risk and well-tolerated procedure for pain palliation in patients with unresectable, painful soft tissue neoplasms. RFA is effective for short-term local pain control and may provide another option for failed chemotherapy or radiation therapy in patients with cancer. However, pain may transiently worsen, and relief is often temporary.
Locklin
Julia K
JK
National Institutes of Health, Warren G. Magnuson Clinical Center, Diagnostic Radiology Department, Building 10, Room 1C660, Bethesda, MD 20892, USA. jhvizda@cc.nih.gov
Mannes
Andrew
A
Berger
Ann
A
Wood
Bradford J
BJ
D017115:Catheter Ablation; D006801:Humans; D010147:Pain Measurement; D010148:Intractable Pain / Q000601:surgery*; D010166:Palliative Care / Q000379:methods*; D012189:Retrospective Studies; D012983:Soft Tissue Neoplasms / Q000503:physiopathology / Q000601:surgery*